Hi Debbie,
Boral (BLD) and CSR are benefiting from a resurgence in local construction, plus Boral now has the benefit of a share buy-back which was announced last week. We like both stocks and can see ongoing strength.
Both Healius (HLS) & Tabcorp (TAH) have essentially doubled from their COVID-19 low. HLS has benefited from increased demand for diagnostics and while we think that theme continues, it will likely be at lower rates. We are neutral HLS after it traded above $4 and see better value in other healthcare stocks.
TAH is hard to get excited about here, we think the easy money is now gone and consolidation around current levels ($4.70) is the likely outcome.